CCMD
PX

Cypress Capital Management (Delaware)’s Praxair Inc PX Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio PX Stock Details PX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,126
Closed -$824K – 158
2018
Q3 		$824K Sell
5,126
-171
-3% -$27.5K 0.14% 86
2018
Q2 		$838K Buy
5,297
+200
+4% +$30.9K 0.16% 82
2018
Q1 		$735K Buy
5,097
+157
+3% +$24.4K 0.14% 86
2017
Q4 		$764K Buy
+4,940
New +$733K 0.15% 81

Other funds holding PX

SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
CAM
Covenant Asset Management Chester, New Jersey $595M AUM 38.14% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
GFP
Gryphon Financial Partners Columbus, Ohio $1.13B AUM 30.28% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Cypress Capital Management (Delaware)'s PX Position: Q4 2018 in Review

Cypress Capital Management (Delaware) sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 5,126 shares — an estimated $824K sold.

Cypress Capital Management (Delaware) first reported a position in PX in Q4 2017 and held it in 4 quarters. The position peaked at $838K in Q2 2018. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Cypress Capital Management (Delaware) reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 5,126 Praxair Inc shares in Q4 2018, an estimated $824K.
  • Cypress Capital Management (Delaware) first reported a position in Praxair Inc in Q4 2017 and held it in 4 quarters.
  • Cypress Capital Management (Delaware)'s Praxair Inc position peaked at $838K in Q2 2018.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2018, filed 5 Feb 2019.